Citations

Mayo Clinic

Showing 10 of 108176 citations.

Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage
Jauch, Edward C. , Lindsell, Christopher J. , Barsan, William G. , Pancioli, Arthur , Brott, Thomas G. , Adeoye, Opeolu M , Khoury, Jane , Broderick, Joseph P.

Stroke | June 23, 2006 | Volume: 37 | Issue: 8 | Pages: 2061-2065

10.1161/01.str.0000229878.93759.a2 | PMID 16794216 Get It

Background and Purpose— Early hematoma expansion in spontaneous intracerebral hemorrhage (ICH) is associated with worse clinical outcome. We hypothesized that hemodynamic parameters are associated with the increase in hematoma volume owing to their relationship to blood vessel wall stresses. Methods— We performed a post hoc analysis of clinical and computed tomography (CT) data from patients enrolled in a prospective observational study of ICH patients presenting within 3 hours from symptom onset. Hematoma volumes were measured at hospital arrival and at 1 and 20 hours from presentation. Blood pressure and heart rate, recorded at 19 time points between presentation and 20 hours, were used to derive hemodynamic variables. Multivariable logistic-regression models were constructed to assess the relation between hemodynamic parameters and hematoma growth, adjusted for clinical covariates. Results— From the original study, 98 patients underwent baseline and 1-hour CT scans; of these, 65 had 20-hour CT scans. Substantial hematoma growth was observed in 28% within the first hour. Of the 65 patients not undergoing surgery within 20 hours, 37% experienced hematoma growth by 20 hours. Neither baseline or peak hemodynamic parameters nor changes in hemodynamic parameters were significantly associated with hematoma growth at either 1 or 20 hours. Conclusions— We found no blood pressure or heart rate parameters, individually or in combination, that were associated with hematoma growth. Our data suggest the influence of hemodynamic parameters on vessel wall stress to be an unlikely target for intervention in reducing the risk of early hematoma growth in ICH.
End Points for Adjuvant Therapy Trials: Has the Time Come to Accept Disease-Free Survival as a Surrogate End Point for Overall Survival?
Sargent, Daniel J. , Gill, Sharlene , Sargent, Daniel J

The Oncologist | June 22, 2006 | Volume: 11 | Issue: 6 | Pages: 624-629

10.1634/theoncologist.11-6-624 | PMID 16794241 Get It

Learning Objectives After completing this course, the reader will be able to: Identify the benefits and caveats of using disease-free survival as a surrogate end point for overall survival in adjuvant therapy trials.Describe the accepted criteria for validating a surrogate end point.Discuss the current applicability of DFS as an end point in adjuvant trials. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com
“MRI and CT Evaluation of Primary Bone and Soft-Tissue Tumors”— Invited Commentary
Kransdorf, Mark J.

American Journal of Roentgenology | June 22, 2006 | Volume: 187 | Issue: 1 | Pages: 16-17

10.2214/ajr.05.1990 | PMID 16794149 Get It

Transhepatic Puncture of Portal and Hepatic Veins for TIPS Using a Single-Needle Pass Under Sonographic Guidance
Raza, Syed Atif, Walser, Eric , Hernández, A , Chen, Keven, Marroquin, Santiago

American Journal of Roentgenology | June 22, 2006 | Volume: 187 | Issue: 1 | Pages: W87-W91

10.2214/ajr.05.1342 | PMID 16794144 Get It

Clinical Trials in Surgery: The Role of the American College of Surgeons Oncology Group
You, Y. Nancy , Wells, Samuel A.

World Journal of Surgery | June 22, 2006 | Volume: 30 | Issue: 7 | Pages: 1147-1151

10.1007/s00268-006-0076-7 | PMID 16794900 Get It

Secondary Structure and Interfacial Aggregation of Amyloid-β(1−40) on Sodium Dodecyl Sulfate Micelles
Rangachari, Vijayaraghavan , Reed, Dana Kim , Moore, Brenda D. , Rosenberry, Terrone L.

Biochemistry | June 22, 2006 | Volume: 45 | Issue: 28 | Pages: 8639-8648

10.1021/bi060323t | PMID 16834338 Get It

Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia
Chade, Alejandro , Zhu, Xiangyang , Mushin, Oren P., Napoli, Claudio , Lerman, Lilach O. , Lerman, Amir

The FASEB Journal | June 21, 2006 | Volume: 20 | Issue: 10 | Pages: 1706-1708

10.1096/fj.05-5680fje | PMID 16790524 Get It

ABSTRACT We tested the hypothesis that statins would decrease renal injury in renal artery stenosis (RAS) by restoring angiogenesis and attenuating intrarenal microvascular (IMV) remodeling. Single‐kidney hemodynamics and function were quantified using electron‐beam‐computed tomography (CT) in normocho‐lesterolemic pigs after 12 wk of experimental RAS, RAS supplemented with simvastatin (RAS+simvastatin), and normal controls. Renal circulation was also studied in vivo using angiography and ex vivo using a unique 3D micro‐CT imaging technique. Angiogenic and remodeling pathways were subsequently explored in renal tissue. Blood pressure and the degree of stenosis were similarly increased in RAS groups. Simvastatin in RAS enhanced both intrarenal angiogenesis and peri‐stenosis arteriogenesis and increased the expression of angiogenic growth factors and hypoxia‐inducible factor‐1α. Furthermore, simvastatin decreased tissue‐transglutaminase expression and IMV inward remodeling, restored IMV endothelial function, decreased fibrogenic activity, and improved renal function. Chronic simvastatin supplementation promoted angiogenesis in vivo, decreased ischemia‐induced IMV remodeling, and improved IMV function in the stenotic kidney, independent of lipid lowering. These novel renoprotective effects suggest a role for simvastatin in preserving the ischemic kidney in chronic RAS.— Chade, A. R., Zhu, X., Mushin, O. P., Napoli, C., Lerman, A., Lerman, L. O. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J. 20, E1014–E1023 (2006)
Use of orlistat in obese, dyslipidemic patients
Nelson, Robert , Miles, John J.

Future Lipidology | June 21, 2006 | Volume: 1 | Issue: 3 | Pages: 267-273

10.2217/17460875.1.3.267 Get It

Strong-Arming Immune Regulation: Suppressing Regulatory T-Cell Function To Treat Cancers
Knutson, Keith L. , Knutson, Keith L.

Future Oncology | June 20, 2006 | Volume: 2 | Issue: 3 | Pages: 379-389

10.2217/14796694.2.3.379 | PMID 16787118 Get It

Surface roughness imaging using the acoustic emission induced by the dynamic radiation force of ultrasound
Mitri, F.G. , Eberlein, U., Fatemi, Mostafa , Fatemi, Mostafa

Applied Physics Letters | June 19, 2006 | Volume: 88 | Issue: 23 | Pages: No page available

10.1063/1.2211187 Get It

High frequency ultrasound imaging systems are traditionally used in industry to obtain high resolution images of solid surfaces, and in some cases, to evaluate surface roughness. In this study we show that imaging fine surface roughness in the order of few microns is achievable at audio range frequencies (kilohertz range) by using the vibroacoustography (VA) technique. This technique allows one to image surface roughness on the basis of the ultrasound radiation force stimulated acoustic emission in a standing ultrasound wave field. Images obtained here demonstrate that VA may be used as a powerful tool for nondestructive inspection and imaging of surface roughness.